Cargando…
Distinct prognostic value of circulating anti-telomerase CD4(+) Th1 immunity and exhausted PD-1(+)/TIM-3(+) T cells in lung cancer
BACKGROUND: Despite the critical roles of Th1-polarised CD4(+) T cells in cancer immunosurveillance, the translation of their potential to clinical use remains challenging. Here, we investigate the clinical relevance of circulating antitumor Th1 immunity in non-small cell lung cancer (NSCLC). METHOD...
Autores principales: | Laheurte, Caroline, Dosset, Magalie, Vernerey, Dewi, Boullerot, Laura, Gaugler, Béatrice, Gravelin, Eléonore, Kaulek, Vincent, Jacquin, Marion, Cuche, Laurie, Eberst, Guillaume, Jacoulet, Pascale, Fabre, Elizabeth, Le Pimpec-Barthes, Françoise, Tartour, Eric, De Carvalho Bittencourt, Marcelo, Westeel, Virginie, Adotévi, Olivier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738094/ https://www.ncbi.nlm.nih.gov/pubmed/31358938 http://dx.doi.org/10.1038/s41416-019-0531-5 |
Ejemplares similares
-
Prognostic value of CD4+ T lymphopenia in non-small cell lung Cancer
por: Eberst, Guillaume, et al.
Publicado: (2022) -
Universal tumor-reactive helper peptides from telomerase as new tools for anticancer vaccination
por: Dosset, Magalie, et al.
Publicado: (2013) -
Telomerase and CD4 T Cell Immunity in Cancer
por: Dosset, Magalie, et al.
Publicado: (2020) -
Is preexisting antitumor CD4 T cell response indispensable for the chemotherapy induced immune regression of cancer?
por: Godet, Yann, et al.
Publicado: (2012) -
The Quality of Anti-SARS-CoV-2 T Cell Responses Predicts the Neutralizing Antibody Titer in Convalescent Plasma Donors
por: Kroemer, Marie, et al.
Publicado: (2022)